Glucose (Glc) and lactate (Lac) are possible fuel molecules, and both the ATP/ADP and NADH/NAD+ pairs are compartmentalized between cytosol and mitochondria, as is [Ca2+]. For mitochondria, the …
(a) Malate-aspartate shuttle (MAS); (b) the glycerol phosphate shuttle (GPS). References in the main text.
Na+ entry through the voltage-activated Na+ channels (NaV) activates the Na+ pump (Na+,K+-ATPase) in the plasma membrane, converting ATP to ADP. Ca2+ entry through the voltage-activated Ca2+ …
(a) Left: Representative traces of two different readouts of the Pyronic sensor, expressed in the cytosol of a dentate granule cell (DGC). The lifetime of the donor species mTFP (black line, left …
(a) Representative images of DGCs expressing the Pyronic sensor, pseudocolored according to the lifetime of the donor species (mTFP). Cells perfused in ACSF only (Control), or in the presence of the …
(a) Top: Low-magnification image of an acute brain slice of the hippocampus, showing the placement of the stimulating electrode in the hilus (H) and the O2 electrode in the layer of dentate granule …
(a) The traces represent the average normalized NAD(P)H signals (mean ± SD) before and after 2 µM UK5099 (as in Figure 2b), elicited by antidromic stimulation. The baseline before each stimulation …
(a) Filmstrip of the metabolic response in the cytosol of stimulated DGCs, before and after the application of 2 µM UK5099 (as in Figure 2c). The images were pseudocolored according to the lifetime …
(a) Representative traces of simultaneously recorded NAD(P)H and FAD+ autofluorescence signals, and RCaMP fluorescence, in a population of DGCs in an acute brain slice. (b) Effects of the sequential …
(a) Representative traces of the NAD(P)H autofluorescence signals and the mitoRCaMP1h transients in response to different trains of depolarizing pulses. The data correspond to simultaneously …
(a) Top: Schematic representation of mitoRCaMP1h. Abbreviations indicate the mitochondrial leader sequence from the Cox8 subunit (as used in Li et al., 2014), added to the RCaMP1h sensor that …
(a) Fluorescence signals from a mitochondrial matrix-targeted Ca2+ sensor (mitoRCaMP) in a population of hemizygous control DGCs (Mcufl/Δ) and MCU-KD DGCs (Mcufl/Δ Dock10-Cre), imaged using …
(a) Average traces of the NAD(P)H signal expressed as the ΔF/Fbaseline-i ratio (mean ± SD of number of slices, sample sizes as in Figure 3b, Right panel). The initial dip of the NAD(P)H signal was …
(a) Comparison of the ΔRCaMP lifetime transient among genotypes (sample size for Mcufl/fl mice: Nneurons = 86, Nslices = 9 and Nmice = 4; sample sizes for Mcufl/Δ and Mcufl/ΔDock10Cre mice as in Figu…
(a) Average traces of the NAD(P)H signal expressed as the ΔF/Fbaseline-i ratio (mean ± SD of number of slices, sample sizes for Mcufl/Δ mice as in Figure 3b, Right panel; sample size for Mcufl/fl: Ns…
(a) Left: Representative trace from a DGC expressing Peredox and RCaMP1h. The slice was superfused for ~20 min with the L-type Ca2+ channel inhibitor isradipine (Isra, 3 µM), and then stimulated. In …
(a) Comparison of the ΔPeredox/ΔRCaMP values obtained in the continuous presence of the LDH inhibitor GSK-2837808A, before and after the blockade of voltage gated Ca2+ channels with a combination of …
Left: Representative trace for the effect of Ca2+ removal from the ACSF on the NADHCYT transients. As in Figure 3—figure supplement 5, no EGTA was added to the solution. Right: Simple substitution …
Left: Representative trace of the effect of DMSO (0.1%) on the Peredox and RCaMP signals. Right: The change in Peredox lifetime elicited by stimulation was unaffected by the application of 0.1% DMSO …
(a) Left: Representative trace of a DGC treated with E6-berbamine (10 µM), an inhibitor of the Ca2+-calmodulin signaling pathway. Right: The magnitude of the metabolic response was expressed as the …
(a) Inhibition of the Ca2+/CaM axis with 10 µM E6-berbamine (E6-Berb) increases the RCaMP lifetime at baseline while keeping the stimulus-associated RCaMP spike intact. The Peredox lifetime at …
(a) Left: Representative trace of Peredox and RCaMP1h lifetimes simultaneously recorded in a DGC from an acute hippocampal slice. The slice was superfused with 2 µM GSK-2837808A for at least 30 min …
(a) The Peredox baseline remained unaltered during the recordings from Figure 6a, where stimulations were delivered ~10 min after changing solutions. The data were compared using a repeated measures …
(a) Left: Representative trace of the autofluorescence and RCaMP signals in the DGC layer of an acute hippocampal slice. These experiments were performed with samples from juvenile wild-type mice. …
Prolonged exposure to a nominal Ca2+-free solution, plus LDH inhibition, caused spontaneous elevations of the Peredox lifetime in 25 ± 13% of the cells in each slice (slices = 10, mice = 5), …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Chemical compound, drug | NBQX (6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione, Disodium Salt) | Toronto Research Chemicals | Cat#N550005; CAS:479347-86-9 | |
Chemical compound, drug | D-AP5 (D-(-)−2-Amino-5-phosphonopentanoic acid) | Abcam | Cat#ab120003; CAS:79055-68-8 | |
Chemical compound, drug | Isradipine | Abcam | Cat#ab120142; CAS:75695-93-1 | |
Chemical compound, drug | α-pompilidotoxin | Alomone Labs | Cat#P-170 | |
Chemical compound, drug | EGTA-AM | Anaspec Inc | Cat#AS-84100; CAS:99590-86-0 | |
Chemical compound, drug | Calmidazolium | Cayman Chemical | Cat#14442; CAS:57265-65-3 | |
Chemical compound, drug | Dorsomorphin dihydrochloride | Tocris Bioscience | Cat#3093; CAS:1219168-18-9 | |
Chemical compound, drug | E6-berbamine | Santa Cruz | Cat#sc-221573; CAS:73885-53-7 | |
Chemical compound, drug | UK5099 | Santa Cruz | Cat#sc-361394; CAS:56396-35-1 | |
Chemical compound, drug | UK5099 | Tocris Bioscience | Cat#5185 | |
Chemical compound, drug | GSK-2837808A | Tocris Bioscience | Cat#5189; CAS:1445879-21-9 | |
Chemical compound, drug | MgCl2 (1M solution) | Teknova | Cat#M0304 | |
Chemical compound, drug | Picrotoxin | Sigma-Aldrich | Cat#P1675; CAS:124-87-8 | |
Chemical compound, drug | Sodium pyruvate | Sigma-Aldrich | Cat#P8574; CAS:113-24-6 | |
Chemical compound, drug | CdCl2 | Sigma-Aldrich | Cat#202908; CAS:10108-64-2 | |
Chemical compound, drug | Strophanthidin | Sigma-Aldrich | Cat#S6626; CAS:66-28-4 | |
Strain, strain background Mus musculus | C57BL/6NCrl mice | Charles River | RRID:IMSR_CRL:27 | |
Strain, strain background Mus musculus | Edil3Tg(Sox2-cre)1Amc/J mice (Sox2-Cre) | The Jackson Laboratory | RRID:IMSR_JAX:004783 | |
Strain, strain background Mus musculus | Mcufl/fl mice | Kwong et al., 2015 | RRID:IMSR_JAX:029817 | |
Strain, strain background Mus musculus | Dock10Cre mice | Kohara et al., 2014 | Tonegawa lab | |
Strain, strain background Mus musculus | Mcufl/Δ mice | This paper | Obtained by germline deletion of the floxed allele, followed by backcrossing; Yellen lab | |
Other | AAV9.Syn.RCaMP1h.WPRE.SV40 | Penn Vector Core | Discontinued | Viral vector |
Recombinant DNA reagent | AAV.CAG.Peredox.WPRE.SV40 | Mongeon et al., 2016 | RRID:Addgene_73807 | |
Recombinant DNA reagent | AAV.Syn.RCaMP1h.WPRE.SV40 | Akerboom et al., 2013 | ||
Recombinant DNA reagent | pZac2.1-CaMKII-mito-GCaMP6s | Li et al., 2014 | ||
Recombinant DNA reagent | AAV.CAG.Pyronic.WPRE.SV40 | San Martín et al., 2014 | Derived from RRID:Addgene_51308 | |
Recombinant DNA reagent | AAV.Syn.mito-RCaMP1h.WPRE.SV40 | This paper | Produced by addition of a mitochondrial targeting signal; Yellen lab | |
Software, algorithm | MATLAB R2014b | Mathworks | RRID:SCR_001622 | |
Software, algorithm | Origin 9.1 | OriginLab | RRID:SCR_002815 | |
Software, algorithm | GraphPad Instat version 3.06 | GraphPad Software | RRID:SCR_000306 | |
Software, algorithm | Microsoft Excel version 2009 | Microsoft | RRID:SCR_016137 |